Repository logo
 
Publication

Biodegradable nanoparticles designed for drug delivery: The number of nanoparticles impacts on cytotoxicity

dc.contributor.authorMendes, Lívia Palmerston
dc.contributor.authorDelgado, Jorge
dc.contributor.authorCosta, Ângela Daniela Alves
dc.contributor.authorVieira, Marcelo Sousa
dc.contributor.authorBenfica, Poliana Lopes
dc.contributor.authorLima, Eliana
dc.contributor.authorValadares, Marize Campos
dc.date.accessioned2018-02-19T10:00:00Z
dc.date.accessioned2018-03-05T10:13:14Z
dc.date.available2018-01-19T10:00:00Z
dc.date.available2018-03-05T10:13:14Z
dc.date.issued2015
dc.description.abstractNanostructured drug delivery systems are based on biocompatible and biodegradable components. Composition, size and membrane surface properties are characteristics that may influence cell viability in cytotoxicity assays. In this work, four nanostructured systems commonly used for drug delivery were prepared and cytotoxicity was evaluated on human lymphocytes and Balb/c 3T3 fibroblasts. The hemolytic potential was also investigated. Polymeric nanocapsules (NC) and nanospheres (NS), nanostructured lipid carriers (NLC) and liposomes were prepared and characterized for size, distribution, zeta potential and number per volume of the colloidal dispersion. Cell viability was evaluated, 24 and 48h, by MTT and neutral red assays (NR). Cells were incubated with each particle in eight different dilutions varying from 2.1×10 <sup > 4 < /sup > to 2.1×10 < sup > 11 < /sup > particles/mL. Diameter of nanoparticles was between 130 and 200nm, all samples exhibited narrow size distribution (polydispersity index below 0.1) and zeta potential varied from -6.8 to -19.5mV. NC, NS and NLC reduced cell viability in a dilution dependent manner. For these nanoparticles, the higher number of particles induced cell death for both cell types. Liposomes did not cause loss of cell viability even at the highest number of particles. Results suggest that, depending on the kind of nanoparticle, the number of particles in the dispersion can negatively influence cell viability in pre-clinical drug development.en_EN
dc.description.sponsorshipThis work was supported by the Brazilian research funding agencies Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Financiadora de Estudos e Pesquisas (FINEP), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Apoio à Pesquisada Universidade Federal de Goiás (FUNAPE) and Fundação de Apoio à Pesquisa do Estado de Goiás (FAPEG).
dc.description.versioninfo:eu-repo/semantics/publishedVersionen_EN
dc.identifier.citationMendes, Lívia Palmerston; Delgado, Jorge Miguel Ferreira; Costa, Angela Daniela A.; Vieira, Marcelo Sousa; Benfica, Poliana Lopes; Lima, Eliana Martins; Valadares, Marize Campos (2015). Biodegradable nanoparticles designed for drug delivery: The number of nanoparticles impacts on cytotoxicity. Toxicology in Vitro. ISSN 0887-2333. 29:6,p. 1268-1274en_EN
dc.identifier.doi10.1016/j.tiv.2014.12.021en_EN
dc.identifier.issn0887-2333
dc.identifier.urihttp://hdl.handle.net/10198/16153
dc.language.isoeng
dc.peerreviewedyesen_EN
dc.subjectIn vitro cytotoxicityen_EN
dc.subjectNanoparticlesen_EN
dc.titleBiodegradable nanoparticles designed for drug delivery: The number of nanoparticles impacts on cytotoxicityen_EN
dc.typejournal article
dspace.entity.typePublication
rcaap.rightsopenAccessen_EN
rcaap.typearticleen_EN

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
261.pdf
Size:
1.55 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.75 KB
Format:
Plain Text
Description: